Reverse Transcription Recombinase-Aided Amplification Assay With Lateral Flow Dipstick Assay for Rapid Detection of 2019 Novel Coronavirus

Frontiers in Cellular and Infection Microbiology

Jian Li¹  Xiao-Nan Song¹  Long Liu¹  Wei-Jia Cheng¹  Tian-Yu Zhong²  Jin-Zhou Wen³  Xiang-Zhi Liu⁴  Hui-Ying Huang⁴  Jiang-Tao Chen⁵  Xian-Jing Wu⁵  Xue-Yan Liang⁶  Lie-Jun Li⁷  Li-Yun Lin⁸  Yu-Zhong Zheng⁸  Guang-Cai Zha⁸  Pei-Kui Yang⁸  Min Lin⁸ 

[1] Department of Human Parasitology, School of Basic Medical Sciences, Hubei University of Medicine, Shiyan, China;Department of Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, China;Department of Medical Laboratory, Center for Disease Control and Prevention, Chaozhou, China;Department of Medical Laboratory, Chaozhou People’s Hospital, Shantou University Medical College, Chaozhou, China;Department of Medical Laboratory, Huizhou Central People’s Hospital, Huizhou, China;Department of Medical Laboratory, Huizhou Central People’s Hospital, Huizhou, China;Department of Medical Laboratory, Chaozhou People’s Hospital, Shantou University Medical College, Chaozhou, China;Department of Research and Development, Chaozhou Hybribio Limited Corporation, Chaozhou, China;School of Food Engineering and Biotechnology, Hanshan Normal University, Chaozhou, China;

关键词: Coronavirus Disease-2019;    Severe Acute Respiratory Syndrome Coronavirus 2;    point of care test;    reverse-transcription recombinase-aided amplification;    lateral flow dipstick;   

DOI  :  10.3389/fcimb.2021.613304

来源: Frontiers

【 授权许可】

CC BY